Impact of baseline clinical and laboratory features on the risk of thrombosis in children with acute lymphoblastic leukemia: A prospective evaluation

Background Children with acute lymphoblastic leukemia (ALL) have increased risk of thromboembolism (TE). However, the predictors of ALL‐associated TE are as yet uncertain. Objective This exploratory, prospective cohort study evaluated the effects of clinical (age, gender, ALL risk group) and laborat...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Pediatric blood & cancer 2018-05, Vol.65 (5), p.e26938-n/a
Hauptverfasser:	Athale, Uma H., Mizrahi, T., Laverdière, C., Nayiager, T., Delva, Y.‐L., Foster, G., Thabane, L., David, M., Leclerc, J.‐M., Chan, A. K. C.
Format:	Artikel
Sprache:	eng
Schlagworte:	ABO blood group ABO system Acute lymphoblastic leukemia Adolescent Age Antithrombin Biomarkers - analysis Blood circulation Blood groups Cancer Cardiolipin Child Child, Preschool Children circulating blasts Coagulation factors Combined Modality Therapy - adverse effects Diagnosis Evaluation Factor V Female Follow-Up Studies Hematology Homocysteine Humans Infant Laboratories Leukemia Lymphatic leukemia Male Methylenetetrahydrofolate reductase Oncology Pediatrics Pilot Projects Precursor Cell Lymphoblastic Leukemia-Lymphoma - therapy Prediction models Prognosis Prospective Studies Proteins Prothrombin Prothrombin gene Risk Factors Tetrahydrofolic acid Thromboembolism Thrombosis Thrombosis - diagnosis Thrombosis - etiology Thrombosis - metabolism Von Willebrand factor
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!